Cardiovascular effects of histamine H3 receptor antagonist JNJ 5207852 in haemorrhagic shock in rats
 
More details
Hide details
1
Department of Basic Medical Sciences, School of Public Health in Bytom, Medical University of Silesia
CORRESPONDING AUTHOR
Jerzy Jochem   

Katedra i Zakład Podstawowych Nauk Medycznych Wydziału Zdrowia Publicznego w Bytomiu Śląskiego Uniwersytetu Medycznego w Katowicach, ul. Piekarska 18, 41-902 Bytom, tel. +48 32 397 65 45
 
Ann. Acad. Med. Siles. 2016;70:89–94
 
KEYWORDS
TOPICS
ABSTRACT
Introduction:
Histamine H3 receptors are widely distributed in the central and peripheral nervous system, including postganglionic adrenergic endings. They act mainly as presynaptic auto- and heteroceptors and are responsible for regulating the synthesis and release of histamine and other neurotransmitters/neuromodulators. The aim of the study was to examine the cardiovascular effects of the histamine H3 receptor blockade in the sympathoinhibitory phase of haemorrhagic shock.

Material and methodss:
Studies were carried out on male Wistar rats anaesthetized with ketamine/xylazine (100 mg/kg + 10 mg/kg, intraperitoneally), subjected to irreversible haemorrhagic shock (0% survival at 2 h) with a mean arterial pressure (MAP) of 20–25 mmHg. At 5 min of critical hypotension, the rats were injected intravenously with H3 receptor antagonist JNJ 5207852 or saline.

Results:
Haemorrhage led to a decrease in pulse pressure (PP) and heart rate (HR). JNJ 5207852 (1 and 5 mg/kg) evoked long-lasting rises in MAP, PP and HR, with an improvement in survival at 2 h (5 mg/kg). Chemical sympathectomy with 6-hydroxydopamine (50 mg/kg for three consecutive days) inhibited cardiovascular changes evoked by JNJ 5207852 and decreased to 0% the survival rate at 2 h in rats treated with JNJ 5207852 (5 mg/kg).

Conclusions:
Histamine H3 receptor antagonist JNJ 5207852 induces the resuscitating effect in haemorrhage-shocked rats, and the mechanism responsible is associated with the activity of postganglionic sympathetic neurons.

 
REFERENCES (29)
1.
Brown R.E., Stevens D.R., Haas H.L. The physiology of brain histamine. Prog. Neurobiol. 2001; 63(6): 637–672.
 
2.
Akins V.F., Bealer S.L. Central nervous system histamine regulates peri-pheral sympathetic activity. Am. J. Physiol. 1991; 260(1 Pt2): H218–H224.
 
3.
Bealer S.L. Central neuronal histamine contributes to cardiovascular regulation. News Physiol. Sci. 1999; 14: 100–105.
 
4.
Jochem J. Endogenous central histamine-induced reversal of critical haemorrhagic hypotension in rats – studies with histamine N-methyltransfe-rase inhibitor SKF 91488. Inflamm. Res. 2002; 51: 551–556.
 
5.
Jochem J. Cardiovascular effects of histamine administered intracerebro-ventricularly in critical haemorrhagic hypotension in rats. J. Physiol. Phar-macol. 2000; 51: 229–239.
 
6.
Jochem J. Involvement of the sympathetic nervous system in the reversal of critical haemorrhagic hypotension by endogenous central histamine in rats. Naunyn Schmiedebergs Arch. Pharmacol. 2004; 369: 418–427.
 
7.
Jochem J. Involvement of the renin-angiotensin system in endogenous central histamine-induced reversal of critical haemorrhagic hypotension in rats. J. Physiol. Pharmacol. 2004; 55: 39–55.
 
8.
Jochem J. Involvement of arginine vasopressin in endogenous central histamine-induced reversal of critical haemorrhagic hypotension in rats. Inflamm. Res. 2004; 53(7): 269–276.
 
9.
Jochem J. Involvement of proopiomenalocortin-derived peptides in endogenous central histamine-induced reversal of critical haemorrhagic hypotension in rats. J. Physiol. Pharmacol. 2004; 55 (1 Pt1): 57–71.
 
10.
Williams K.W., Sharma H.P. Anaphylaxis and urticaria. Immunol. Allergy Clin. North Am. 2015; 35(1): 199–219.
 
11.
Arrang J.M., Garbarg M., Schwartz J.C. Auto-inhibition of brain histamine release mediated by a novel class (H3) of histamine receptor. Nature 1983; 302: 832–837.
 
12.
Lovenberg T.W., Roland B.L., Wilson S.J., Jiang X., Pyati J., Huvar A., Jackson M.R., Erlander M.G. Cloning and functional expression of the human histamine H3 receptor. Mol. Pharmacol. 1999; 55: 1101–1107.
 
13.
Schwartz J.C. The histamine H3 receptor: from discovery to clinical trials with pitolisant. Br. J. Pharmacol. 2011; 163: 713–721.
 
14.
Ishikawa S., Sperelakis N. A novel class (H3) of histamine receptors on perivascular nerve terminals. Nature 1987; 327: 158–160.
 
15.
Li M., Hu J., Chen Z., Meng J., Wang H., Ma X., Luo X. Evidence for histamine as a neurotransmitter in the cardiac sympathetic nervous system. Am. J. Physiol. Heart. Circ. Physiol. 2006; 291: H45–H51.
 
16.
Ea-Kim L., Oudart N. A highly potent and selective H3 agonist relaxes rabbit middle cerebral artery, in vitro. Eur. J. Pharmacol. 1988; 150: 393–396.
 
17.
Malinowska B., Schlicker E. H3 receptor-mediated inhibition of the neurogenic vasopressor response in pithed rats. Eur. J. Pharmacol. 1991; 205: 307–310.
 
18.
Schadt J.C., Ludbrook J. Hemodynamic and neurohumoral responses to acute hypovolemia in conscious mammals. Am. J. Physiol. 1991; 260: H305–H318.
 
19.
Secher N.H., Jacobsen J., Friedman D.B., Matzen S. Bradycardia during reversible hypovolaemic shock: associated neural reflex mechanisms and clinical implications. Clin Exp Pharmacol Physiol 1992; 19: 733–743.
 
20.
Bai J., Ren C., Hao W., Wang R., Cao J.M. Chemical sympathetic denervation, suppression of myocardial transient outward potassium current, and ventricular fibrillation in the rat. Can. J. Physiol. Pharmacol. 2008; 86: 700–709.
 
21.
Guarini S., Bazzani C., Cainazzo M.M., Mioni C, Ferrazza G, Vergoni AV, Schiöth HB, Wikberg JE, Bertolini A. Evidence that melanocortin 4 receptor mediates hemorrhagic shock reversal caused by melanocortin peptides. J. Pharmacol Exp. Ther. 1999; 291: 1023–1027.
 
22.
Abuhamdah R.M., van Rensburg R., Lethbridge N.L., Ennaceur A., Chazot P.L. Effects of methimepip and JNJ-5207852 in Wistar rats exposed to an open-field with and without object and in Balb/c mice exposed to a radialarm maze. Front. Syst. Neurosci. 2012; 6: 54.
 
23.
Jochem J., Żwirska-Korczala K., Gwóźdź B., Walichiewicz P., Jośko J. Cardiac and regional haemodynamic effects of endothelin-1 in rats subjected to critical haemorrhagic hypotension. J. Physiol. Pharmacol. 2003; 54: 383–396.
 
24.
Jochem J. Haematological, blood gas and acid-base effects of central histamine-induced reversal of critical haemorrhagic hypotension in rats. J. Physiol. Pharmacol. 2001; 52: 447–458.
 
25.
Barbier A.J., Berridge C., Dugovic C., Laposky A.D., Wilson S.J., Boggs J., Aluisio L., Lord B., Mazur C., Pudiak C.M., Langlois X., Xiao W., Apodaca R., Carruthers N.I., Lovenberg T.W. Acute wake-promoting actions of JNJ-5207852, a novel, diamine-based H3 antagonist. Br. J. Pharmacol. 2004; 143: 649–661.
 
26.
Jia F., Kato M., Dai H., Xu A., Okuda T., Sakurai E., Okamura N., Lovenberg T.W., Barbier A., Carruthers N.I., Iinuma K., Yanai K. Effects of histamine H(3) antagonists and donepezil on learning and mnemonic deficits induced by pentylenetetrazol kindling in weanling mice. Neuro-pharmacology 2006; 50: 404–411.
 
27.
Jiang X.H., Guo S.Y., Xu S., Yin Q.Z., Ohshita Y., Naitoh M., Horibe Y., Hisamitsu T. Sympathetic nervous system mediates cold stress-induced suppression of natural killer cytotoxicity in rats. Neurosci. Lett. 2004; 358: 1–4.
 
28.
Wang M., Tanida M., Shibamoto T., Kurata Y. Alpha-adrenoceptor antagonists and chemical sympathectomy exacerbate anaphylaxis-induced hypotension, but not portal hypertension, in anesthetized rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2013; 305: R900–R907.
 
29.
Jiao Y.Y., Guo S.Y., Umezawa T., Okada M., Hisamitsu T. The sympathetic nervous system is involved in the inhibitory effect of morphine on the colon motility in rats. Auton. Neurosci. 2002; 100: 27–31.
 
eISSN:1734-025X